Blog Greenlight Biosciences Blog March 26, 2021 –– Blog A blueprint to vaccinate the world Read More Bloomberg: GreenLight Is Mass-Producing RNA to Fight Crop Pests News10NBC: GreenLight Biosciences opens new RNA facility in Rochester The New York Times: Vaccines for Africa How to scale RNA production GreenLight Biosciences opens RNA production facility for the next generation of agricultural products Jennifer Raymond welcomed as SVP, CMC and Manufacturing STAT: RNA firm GreenLight Biosciences to go public in $1.2 billion deal The Wall Street Journal: RNA Tech Firm GreenLight Biosciences to Go Public in $1.5 Billion SPAC Deal END Points News: Virtually unknown mRNA upstart rides SPAC to Nasdaq Kimberley Warren welcomed as SVP Business Development, Human Health Protecting honey bees with RNA Unherd: Why third jabs are inevitable Science Magazine: How to vaccinate the world Sustaining Ladybug Life The Economist: RNA for Bees and Crops Protecting honeybees from the Varroa destructor mite GreenLight acquires Bayer’s topical RNA Intellectual Property portfolio GenEdge: GreenLight Strives for Global RNA Equity The National: Africa needs to be self-reliant in vaccine production Amin Khan welcomed as Chief Scientific Officer, Human Health Financial Times: How to vaccinate the world GreenLight partners with Fraunhofer IME A blueprint to vaccinate the world The Economist: Novel vaccines performed well Nature: Innovators target vaccines for variants BioSpace: Feasibility study for powder form of Covid vaccine Feasibility Arrangement for shelf-stable powder form of COVID-19 Vaccine Candidate Vox: Lipid nanoparticles are essential to Covid vaccines Mark Singleton welcomed as lead for plant health innovation CNN: Critical component for Covid-19 vaccines is in short supply Washington Post: scarcity of biotech ingredients Elemental: All about mRNA The Economist: Covid-19 vaccine resource difficulties Business Insider: GreenLight named as one of six biotechs VCs are watching Financial Times: If Covid vaccines stop working, how quickly can drugmakers respond? Business Journal: Boston firms developing Covid vaccines STAT Opinion: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines Financial Times: Get vaccine new variant ready Mail Online: Vaccine roll out issues Financial Times: Vaccine makers race to fix vaccine supply issues Five Question Friday: Archie Mathura Technology Review: What are the Pfizer covid-19 vaccine ingredients? Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped Investors Business Daily: Vaccine manufacturing challenge #WFH Series: Elisha Fielding CNBC: The challenges of Covid-19 vaccine production for the masses BioSpace: Harnessing Nature for Faster mRNA Vaccine Manufacturing Wired: Manufacturing enough Covid-19 vaccine is a logistical nightmare #WFH Series: Evelien Van Ekert Daily Mail: Suppliers of vaccine materials do not have capacity